Delix Therapeutics develops neuroplastogens, a novel class of compounds that promote neuroplasticity to enhance brain health. Their approach targets neuropsychiatric conditions by repairing neural circuits and improving mental function through safe and fast-acting treatments.
Funding
$108.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
USFounders
Product
Problem
Current treatments for neuropsychiatric and neurodegenerative conditions often fall short, with a significant percentage of patients exhibiting resistance or experiencing only partial symptom relief. There remains a substantial unmet need for novel therapeutics that can effectively address the underlying structural and functional deficits in the brain associated with these disorders.
Solution
Delix Therapeutics is developing neuroplastogens, a novel class of compounds designed to promote neuroplasticity and enhance brain health. These therapeutics aim to repair neural circuits and improve mental function by directly influencing the brain's ability to grow and form new connections. Delix's approach focuses on inducing selective neuroplasticity to rewire specific neural circuits affected by neuropsychiatric conditions. The company is developing a diversified pipeline of neuroplastogens with the potential to address a range of neuropsychiatric and neurodegenerative indications.
Target Audience
The primary target audience includes individuals suffering from neuropsychiatric and neurodegenerative conditions, as well as clinicians and researchers seeking novel therapeutic interventions for these disorders.
Features
- Novel class of compounds (neuroplastogens) designed to promote neuroplasticity.
- Focus on repairing neural circuits and improving mental function.
- Induces selective neuroplasticity to rewire precise neural circuits.
- Pipeline includes over 1500 compounds based on more than 10 unique chemical scaffolds.
- Targets a range of neuropsychiatric and neurodegenerative indications.